Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,664 across all filing types
Latest filing 2018-10-30 Board/Management Inform…
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Director and Company Secretary Appointment 4 pages 508.8KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement regarding the appointment of a new Non-Executive Director and Company Secretary, Mr. Steve Denaro. It includes details about his background, terms of appointment, and an Appendix 3X Initial Director’s Interest Notice, which is a regulatory form related to director shareholdings and interests. There are no financial statements, earnings data, or detailed management discussion. The content focuses on board/management changes and director interests. Therefore, the document fits the category of Board/Management Information (MANG). The presence of the Appendix 3X does not change the classification as it is part of director-related disclosures, not a major shareholding notification or insider trading report. Confidence is high due to clear and explicit content about director appointment and related disclosures.
2018-10-30 English
Director Appointment/Resignation 2 pages 145.7KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement regarding the resignation of a director, Ms Catherine Costello, from her roles as interim Executive Director and Company Secretary. It includes details about the resignation date, previous appointment dates, and a mention of an attached Appendix 3Z (Final Director’s Interest Notice). There is no financial data, report, or presentation content. The document is clearly about a change in the company's board or senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming this classification.
2018-10-28 English
Final Directors Interest Notice 2 pages 206.2KB
Director's Dealing Classification · 95% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the securities interests of a director who has ceased to be a director, including unlisted options held. The content focuses on the director's personal share transactions and interests, which aligns with insider trading or director dealings disclosures. The document length is 2363 characters, which is relatively short and specific to director interests. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives. Therefore, the correct classification is DIRS with high confidence.
2018-10-28 English
Director Appointment/Resignation 7 pages 525.8KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 4 October 2018 regarding the resignation of Dr Simon Buckingham as Non-Executive Director and the appointment of Dr Wenyi Gu as Non-Executive Director of Admedus Limited. It includes detailed biographical information about the new director and statements from the Chairman. The document also contains Appendix 3Z (Final Director’s Interest Notice) for the resigning director and Appendix 3X (Initial Director’s Interest Notice) for the newly appointed director, which are standard regulatory forms disclosing directors' interests in securities. There is no financial data, earnings information, or report content. The primary focus is on changes in the company's board of directors. Therefore, this document fits the category of Board/Management Information (MANG). The document length (8545 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2018-10-03 English
Correction cover letter Notice of Initial Substantial Holder 1
Regulatory Filings Classification · 95% confidence The document is a correction letter regarding a previously lodged Notice of Initial Substantial Holder (Form 603) for Admedus Limited. It clarifies the correct name of the substantial holder group. The document is short (1987 characters) and is a regulatory announcement related to shareholding notifications but does not itself constitute a new substantial shareholding notification. It is not a full report, financial statement, or detailed filing but a correction to a prior regulatory filing. Given the nature of the document and the correction to a substantial holder notice, the most appropriate classification is Regulatory Filings (RNS), as it is a miscellaneous regulatory announcement that does not fit other specific categories.
2018-09-17 English
Becoming a substantial holder 27 pages 9.1MB
Regulatory Filings
2018-09-16 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.